CDH1 and cancer: Pathway enrichment analysis was most significant for evidence of epithelial-mesenchymal transition (EMT) in the C1 tumors, with concordant loss of E-cadherin (CDH1) and upregulation of CXCL14, both prognostic biomarkers in diverse other cancers (Supplementary Table S12, Fig. 2d–f)23–25.